Gong Xiaolei, Chai Miao, Tan Xiaolin, Li Linyu, Guo Changwei, Yang Jie, Liu Guojian, Wang Lilan, Shi Xiaolie, Yang Shihai, Ma Jinfu, Xu Xu, Yang Dahong, Sun Wenzhe, Fan Shitao, Song Jiaxing, Zi Wenjie, Zhang Zhenchang
Department of Neurology, Second Hospital of Lanzhou University, Gansu. No.82 Cuiyingmen, Chengguan District, Lanzhou, 730030, Gansu, China.
Department of Neurology, Meishan Second People's Hospital, Sichuan, China.
J Neurol. 2025 May 13;272(6):395. doi: 10.1007/s00415-025-13144-7.
The effectiveness and safety of endovascular therapy (EVT) in patients with Acute Basilar Artery Occlusion (ABAO) with low pc-ASPECTS is unclear.
To evaluate the effectiveness and safety of EVT in ABAO patients with low pc-ASPECTS.
We analyzed 199 ABAO patients with pc-ASPECTS ≤ 6 who were prospectively registered in the BASILAR study. The patients were divided into the standard medical treatment group (SMT group) and the endovascular therapy group (EVT group). We compared the differences between the two groups in terms of primary outcomes (mRS scores of 0-3, 0-2 and 0-1 at 1 year), secondary outcomes (mRS scores of 0-3, 0-2 and 0-1 at 90 days), primary safety outcomes (symptomatic intracranial haemorrhage at 48 h, mortality at 90 days).
Among the 199 patients, 134 (67.34%) were in the EVT group. Compared with the SMT group, the EVT group showed a significantly higher likelihood of achieving mRS score of 0-3 [adjusted OR [aOR] 21.17, 95% CI (2.08-215.43), P = 0.010] and mRS score of 0-2 [aOR 16.34, 95% CI (1.64-163.32), P = 0.017] at 1 year. There was no significant difference in safety outcomes at 90 days between the two groups.
EVT improves long-term clinical outcomes in ABAO patients with pc-ASPECTS ≤ 6, patients undergoing EVT demonstrated significantly better functional outcomes at 1 year compared to those receiving SMT, with no significant difference in mortality at 90 days. Overall, ABAO patients treated with EVT achieve both effective and safe outcomes.
血管内治疗(EVT)在低灌注-脑缺血性卒中预测评分(pc-ASPECTS)的急性基底动脉闭塞(ABAO)患者中的有效性和安全性尚不清楚。
评估EVT在低pc-ASPECTS的ABAO患者中的有效性和安全性。
我们分析了前瞻性纳入基底动脉研究的199例pc-ASPECTS≤6的ABAO患者。将患者分为标准药物治疗组(SMT组)和血管内治疗组(EVT组)。我们比较了两组在主要结局(1年时改良Rankin量表[mRS]评分为0-3、0-2和0-1)、次要结局(90天时mRS评分为0-3、0-2和0-1)、主要安全结局(48小时内症状性颅内出血、90天时死亡率)方面的差异。
199例患者中,134例(67.34%)在EVT组。与SMT组相比,EVT组在1年时达到mRS评分为0-3[调整后比值比[aOR]21.17,95%置信区间(CI)(2.08-215.43),P=0.010]和mRS评分为0-2[aOR 16.34,95%CI(1.64-163.32),P=0.017]的可能性显著更高。两组在90天时的安全结局无显著差异。
EVT可改善pc-ASPECTS≤6的ABAO患者的长期临床结局,与接受SMT的患者相比,接受EVT的患者在1年时功能结局明显更好,90天时死亡率无显著差异。总体而言,接受EVT治疗的ABAO患者取得了有效且安全的结局。